What is Mainz Biomed N.V. (QUCY) stock price today?

Mainz Biomed N.V. (QUCY) currently trades at $0.43 per share. The stock has a market capitalization of $6.28M and a P/E ratio of —x.

Is QUCY stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Mainz Biomed N.V. has a Smart Value Score of 13/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Mainz Biomed N.V.'s revenue and earnings?

Mainz Biomed N.V. has trailing twelve-month (TTM) revenue of $537080.00 with profit margins of 0.00%. Earnings per share (EPS) is $-2.70.

QUCY

Mainz Biomed N.V.

NASDAQ: QUCY · HEALTHCARE · DIAGNOSTICS & RESEARCH

$0.43

-6.65% today

Updated 2026-04-30

Market cap

$6.28M

P/E ratio

—

P/S ratio

11.69x

EPS (TTM)

$-2.70

Dividend yield

—

52W range

$0 – $1

Volume

0.8M

Market cap

$6.28M

P/E ratio

—

P/S ratio

11.69x

EPS (TTM)

$-2.70

Dividend yield

—

52W range

$0 – $1

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-12.03M

- Revenue declining -32.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$529877.00	$895479.00	$893991.00	$537080.00	$537080.00
Net income	$-26.39M	$-26.30M	$-21.65M	$-16.21M	$-16.21M
EPS	—	—	—	—	$-2.70
Free cash flow	$-15.43M	$-23.84M	$-17.34M	$-12.03M	$-12.03M
Profit margin	-4,979.90%	-2,936.50%	-2,421.80%	-3,018.31%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
QUCY	$6.28M	13	3.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Mainz Biomed N.V. trades at $0.43. Our Smart Value Score of 13/100 indicates the stock is weak. TTM revenue stands at $537080.00.

Frequently asked questions

What is Mainz Biomed N.V.'s stock price?

Mainz Biomed N.V. (QUCY) trades at $0.43.

Is Mainz Biomed N.V. overvalued?

Smart Value Score 13/100 (Grade F, Strong Sell).

What is the price target of Mainz Biomed N.V. (QUCY)?

The analyst target price is $—, representing NaN% downside from the current price of $0.43.

What is Mainz Biomed N.V.'s revenue?

TTM revenue is $537080.00.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio11.69x

ROE-488.30%

Beta0.47

50D MA$0.60

200D MA$1.21

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

QUCY vs LLY →QUCY vs JNJ →QUCY vs ABBV →Stock screener →